Drugs / Mesenchymal stem cell therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04492501 | Apr → Jul 2020 | COVID-19, acute respiratory distress syndrome, cytokine release syndrome | UNICEF | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mesenchymal stem cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04492501 ↗ |
| Modality | Cell therapy | “Mesenchymal stem cell therapy” NCT04492501 ↗ |